FDA Orders Nationwide Recall of American Regent Epinephrine Vials Over Sterility and Contamination Risks

Key points

• The recall covers three specific lots of Epinephrine Injection, USP 30 mg/30 mL (1 mg/mL) multi-dose vials manufactured by American Regent, Inc. in New Albany, Ohio.
• The affected lot numbers are 25128L1C0 (exp. Aug 2026), 25280L1C0 (exp. Oct 2026), and 26108L1C0 (exp. July 2027), all distributed nationwide.
• The recall was triggered by customer complaints of leaking and cracked vials, which compromised sterility assurance, as well as the presence of foreign particulate matter.
• Investigations revealed particulate matter consisting of nylon, cellulosic material, acrylic, polyethylene, and glass within the vials.
• Intravenous administration of contaminated epinephrine could lead to serious health consequences, including blood vessel blockage, pulmonary embolism, organ damage, or death.
• As of September 3, 2026, American Regent had not received any reports of adverse events related to the recalled products.

Background

This recall follows a series of recent FDA actions regarding sterility issues in medical and consumer products. In August 2026, nearly 40,000 bottles of Clear Eyes eye drops were recalled for similar sterility concerns, and in July 2026, over 12 million Rohto eye drops were pulled from shelves for failing sterility standards. These incidents highlight ongoing scrutiny of product integrity in the pharmaceutical and consumer health sectors.

How outlets are covering it

All four sources (WESH, USA Today, NTD News, and The Sun Times News) agree on the core facts: the recall is voluntary, initiated by American Regent, and involves three specific lots of epinephrine injections. WESH and USA Today provide detailed distribution dates and lot numbers, while NTD News emphasizes the potential life-threatening risks of particulate matter entering the bloodstream. The Sun Times News frames the recall as an 'urgent' consumer safety warning. There is no disagreement on the facts, but the emphasis varies: WESH and USA Today focus on the logistical details of the recall, while NTD News and The Sun Times News highlight the severity of the health risks and the immediate action required by consumers.

Why it matters

Epinephrine is a critical, life-saving medication used to treat severe allergic reactions (anaphylaxis) and septic shock. A recall of this nature poses a direct risk to patients who rely on this drug for emergency treatment. The presence of particulate matter and compromised sterility could lead to fatal complications if the affected vials are used. This recall underscores the importance of verifying product integrity and following FDA guidance to ensure patient safety.

What to watch

American Regent is notifying distributors and customers via letter and arranging for the return or replacement of all recalled products. Consumers who possess the affected vials should stop using them immediately and contact their healthcare provider or American Regent’s customer service line (1-800-645-1706) for further instructions. The FDA will continue to monitor the situation for any reported adverse events.